Studies have reported that the downregulation of CBX7 in glioblastoma is caused by hypermethylation of its promoter [17, 24], but the specific DNA methyltransferases (DNMTs) mediating CBX7 promoter hypermethylation have not been elucidated. The gene discussed is CBX7; the disease is glioblastoma.